Supha Pharmachem Limited (BOM:539561)
India · Delayed Price · Currency is INR 0.4600
+0.0200 (4.55%)
At close: Apr 20, 2026
Supha Pharmachem Market Cap
Supha Pharmachem has a market cap or net worth of 185.47 million as of April 20, 2026. Its market cap has decreased by -78.20% in one year.
Market Cap
185.47M
Enterprise Value
11.05B
Revenue
5.27B
Ranking
n/a
PE Ratio
2.46
Stock Price
0.46
Market Cap Chart
Since May 25, 2018, Supha Pharmachem's market cap has increased from 45.36M to 185.47M, an increase of 308.89%. That is a compound annual growth rate of 19.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 177.41M | -41.33% |
| Dec 31, 2025 | 302.40M | -85.35% |
| Dec 31, 2024 | 2.06B | -79.58% |
| Dec 29, 2023 | 10.11B | 1,895.62% |
| Dec 30, 2022 | 506.52M | 1.22% |
| Dec 31, 2021 | 500.40M | 194.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 25, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Smruthi Organics | 1.37B |
| Tyche Industries | 1.32B |
| Krebs Biochemicals & Industries | 1.31B |
| Resonance Specialties | 1.14B |
| Bacil Pharma | 775.21M |
| Alfavision Overseas (India) | 510.72M |
| Vasundhara Rasayans | 420.32M |
| Venmax Drugs and Pharmaceuticals | 301.74M |